Literature DB >> 29891531

Autophagy in cancer: a complex relationship.

Lindsay Wilde1, Katherina Tanson2, Joseph Curry3, Ubaldo Martinez-Outschoorn4.   

Abstract

Macroautophagy is the process by which cells package and degrade cytosolic components, and recycle the breakdown products for future use. Since its initial description by Christian de Duve in the 1960s, significant progress has been made in understanding the mechanisms that underlie this vital cellular process and its specificity. Furthermore, macroautophagy is linked to pathologic conditions such as cancer and is being studied as a therapeutic target. In this review, we will explore the connections between autophagy and cancer, which are tumor- and context-dependent and include the tumor microenvironment. We will highlight the importance of tumor compartment-specific autophagy in both cancer aggressiveness and treatment.
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  autophagy; chemotherapy; glutaminolysis

Mesh:

Year:  2018        PMID: 29891531     DOI: 10.1042/BCJ20170847

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  PAQR3 suppresses the growth of non-small cell lung cancer cells via modulation of EGFR-mediated autophagy.

Authors:  Qianqian Cao; Xue You; Lijiao Xu; Lin Wang; Yan Chen
Journal:  Autophagy       Date:  2019-08-30       Impact factor: 16.016

Review 2.  The Multifunctional Protein p62 and Its Mechanistic Roles in Cancers.

Authors:  Shunbin Ning; Ling Wang
Journal:  Curr Cancer Drug Targets       Date:  2019       Impact factor: 3.428

3.  Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients.

Authors:  Jieping Qiu; Mengyu Sun; Yaoqun Wang; Bo Chen
Journal:  Cancer Cell Int       Date:  2020-05-20       Impact factor: 5.722

Review 4.  Regulation of Autophagy by Non-Steroidal Anti-Inflammatory Drugs in Cancer.

Authors:  Xiangjie Fu; Tan Tan; Peijun Liu
Journal:  Cancer Manag Res       Date:  2020-06-16       Impact factor: 3.989

5.  p62-mediated Selective autophagy endows virus-transformed cells with insusceptibility to DNA damage under oxidative stress.

Authors:  Ling Wang; Mary E A Howell; Ayrianna Sparks-Wallace; Caroline Hawkins; Camri A Nicksic; Carissa Kohne; Kenton H Hall; Jonathan P Moorman; Zhi Q Yao; Shunbin Ning
Journal:  PLoS Pathog       Date:  2019-04-24       Impact factor: 6.823

6.  Moving miRNAs to therapeutic targets in colorectal cancer.

Authors:  Mark McGregor; Timothy J Price
Journal:  EBioMedicine       Date:  2019-05-03       Impact factor: 8.143

7.  High expression of TFEB is associated with aggressive clinical features in colorectal cancer.

Authors:  Jing Liang; Xinfeng Jia; Kun Wang; Niankun Zhao
Journal:  Onco Targets Ther       Date:  2018-11-13       Impact factor: 4.147

8.  A Novel E2F1-EP300-VMP1 Pathway Mediates Gemcitabine-Induced Autophagy in Pancreatic Cancer Cells Carrying Oncogenic KRAS.

Authors:  Alejandro Ropolo; Cintia Catrinacio; Felipe Javier Renna; Veronica Boggio; Tamara Orquera; Claudio D Gonzalez; Maria I Vaccaro
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-23       Impact factor: 5.555

Review 9.  Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer.

Authors:  Yasuyoshi Miyata; Tomohiro Matsuo; Kyohei Araki; Yuichiro Nakamura; Yuji Sagara; Kojiro Ohba; Hideki Sakai
Journal:  Medicines (Basel)       Date:  2018-08-10

10.  Targeting V-ATPase Isoform Restores Cisplatin Activity in Resistant Ovarian Cancer: Inhibition of Autophagy, Endosome Function, and ERK/MEK Pathway.

Authors:  Arpita Kulshrestha; Gajendra K Katara; Safaa A Ibrahim; Valerie Riehl; Manoranjan Sahoo; James Dolan; Kyle W Meinke; Michael R Pins; Kenneth D Beaman
Journal:  J Oncol       Date:  2019-04-01       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.